IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Mydecine Innovations G F

CUSIP: 62849F200 | 3 institutional holders

Quarters

Q3 2025Q2 2025Q1 2025Q2 2024Q2 2022
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2025

Hurley Capital, LLC100
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Hurley Capital, LLC
100$00.0%ETFLowNew York, NY2025-11-12